Cargando…
Hyperammonemic Encephalopathy in a Patient with Pancreatic Neuroendocrine Tumor and Portosystemic Shunt
Hyperammonemia can lead to encephalopathy and may be accompanied by a diagnostic dilemma. Imaging as well as biochemical analyses are the cornerstone for identifying possible underlying causes such as severe liver disease or urea cycle defect. We report a case of a patient that presented with neurol...
Autores principales: | Zorgdrager, Marcel, Cuperus, Frans J. C., de Haas, Robbert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914007/ https://www.ncbi.nlm.nih.gov/pubmed/36766677 http://dx.doi.org/10.3390/diagnostics13030572 |
Ejemplares similares
-
Extrahepatic portosystemic shunts as an unusual but treatable cause
of hyperammonemic encephalopathy in a noncirrhotic patient – a case
report
por: Kühne Escolà, Jordi, et al.
Publicado: (2022) -
Pancreatic Neuroendocrine Tumor-Induced Hyperammonemic Encephalopathy in the Absence of Hepatic Involvement
por: Monardo, Ann S., et al.
Publicado: (2020) -
Adult‐onset noncirrhotic hyperammonemic encephalopathy probably caused by splenorenal shunts
por: Yoshizawa, Kazuhiro, et al.
Publicado: (2022) -
Non-Hyperammonemic valproate encephalopathy
por: Farooq, Omar, et al.
Publicado: (2014) -
Multiple Myeloma-Induced Hyperammonemic Encephalopathy
por: Murtaza, Ghulam, et al.
Publicado: (2017)